Home Newsfeeds Maxim Group Downgrades Synaptogenix to Hold

Maxim Group Downgrades Synaptogenix to Hold

Maxim Group analyst Jason McCarthy downgrades Synaptogenix (NASDAQ:SNPX) from Buy to Hold.

byBenzinga Newsdesk

December 19, 2022

1 minute read

Maxim Group analyst Jason McCarthy downgrades Synaptogenix (NASDAQ:SNPX) from Buy to Hold.

Gene Munster And Dan Ives Disagree On Apple’s Alleged Foray Into Personal Home Robots: ‘It Would Be A Horror Show…’

By Ananya Gairola

April 5, 7:32 AM

Wedbush analyst Ives stated that the market wants Apple to concentrate on enhancing its AI capabilities and not delve into robotics.

AAPL

News

BitNile’s Subsidiary, TurnOnGreen, Awarded State, Federal, And Utility Certifications For Its Electric Vehicle Chargers

By Benzinga Newsdesk

July 18, 6:31 AM

BitNile Holdings, Inc. (NYSE:NILE) announced today that its green energy technology and power supply subsidiary, TurnOnGreen, Inc. (“TurnOnGreen”), has multiple Level 2 Electrical Vehicle (“EV”)

NILE

News

Synaptogenix Granted US Patent #11,390,596 Titled ‘PKC-activating compounds for the treatment of neurodegenerative diseases (including Alzheimer’s disease and stroke)’

By Benzinga Newsdesk

July 19, 2:11 PM

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=11390596.PN.&OS=PN/11390596&RS=PN/11390596

SNPX

Driving Innovation: ECARX And Black Sesame Strengthens Pact To Revolutionize Intelligent Vehicle Solutions

By Nabaparna Bhattacharya

December 22, 10:16 AM

ECARX Holdings Inc. (NASDAQ: ECX) stated Friday that it has signed a new strategic partnership collaboration with Black Sesame Technologies, an automotive-grade SoC and SoC-based

Maxim Group Downgrades Synaptogenix to Hold

Related Posts

Gene Munster And Dan Ives Disagree On Apple’s Alleged Foray Into Personal Home Robots: ‘It Would Be A Horror Show…’

BitNile’s Subsidiary, TurnOnGreen, Awarded State, Federal, And Utility Certifications For Its Electric Vehicle Chargers

Synaptogenix Granted US Patent #11,390,596 Titled ‘PKC-activating compounds for the treatment of neurodegenerative diseases (including Alzheimer’s disease and stroke)’

Driving Innovation: ECARX And Black Sesame Strengthens Pact To Revolutionize Intelligent Vehicle Solutions